BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 30095864)

  • 1. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
    Persa OD; Knuever J; Mauch C; Schlaak M
    J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 years.
    Baecher H; Gerken M; Knoedler L; Knoedler S; Alfertshofer M; Klinkhammer-Schalke M; Berneburg M; Drexler K; Haferkamp S
    J Plast Reconstr Aesthet Surg; 2024 May; 92():33-47. PubMed ID: 38489985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
    Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
    Rios-Cantu A; Lu Y; Melendez-Elizondo V; Chen M; Gutierrez-Range A; Fadaki N; Thummala S; West-Coffee C; Cleaver J; Kashani-Sabet M; Leong SPL
    Clin Exp Metastasis; 2017 Jun; 34(5):345-350. PubMed ID: 28699042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage IIIa Melanoma and Impact of Multiple Positive Lymph Nodes on Survival.
    Woeste MR; McMasters KM; Egger ME
    J Am Coll Surg; 2021 Apr; 232(4):517-524.e1. PubMed ID: 33316426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.
    Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
    Eur J Surg Oncol; 2020 Feb; 46(2):263-271. PubMed ID: 31594672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
    Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
    J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
    Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
    Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
    Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
    Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Lymph Node Basin Drainage in Trunk Melanoma Is Not Associated with Survival of Sentinel Lymph Node-Positive Patients.
    Ribero S; Osella Abate S; Pasquali S; Rossi CR; Borgognoni L; Piazzalunga D; Solari N; Schiavon M; Brandani P; Ansaloni L; Ponte E; Silan F; Sommariva A; Bellucci F; Macripò G; Quaglino P;
    Dermatology; 2017; 233(2-3):205-211. PubMed ID: 28738392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
    Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
    J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
    Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer NH; Berking C; Sunderkötter C; Kaatz M; Schatton K; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Verver D; Martus P; Garbe C;
    J Clin Oncol; 2019 Nov; 37(32):3000-3008. PubMed ID: 31557067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
    Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
    Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
    Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
    Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
    Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
    Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
    Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.